Options Achieves VMware Cloud Verified Status

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Options Technology, today announced it has achieved VMware…

Cambridge Mobile Telematics Partners With Aioi Nissay Dowa Insurance to Launch Japan’s First Large Scale Usage-based Insurance Program

TOKYO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--#PAYD--Aioi Nissay Dowa Insurance Company Limited (Aioi Nissay Dowa Insurance), a…

IPification Wins Award for Most Innovative Mobile Authentication Solutions Company at the European Enterprise Awards

HONG KONG--(BUSINESS WIRE)--#authnetication--Benefit Vantage Limited, the company behind IPification, one-click, passwordless mobile authentication, mobile phone…

BitTitan Names Manoj Kalyanaraman New VP of Product and Engineering

Proven product leader brings engineering experience in payments, fintech, and hospitality industries to new role…

$448 Million PET Foam Market by Raw Material, Grade, Application, Region – Global Forecast to 2025 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "PET Foam Market by Raw Material (Virgin PET and Recycled PET), Grade (Low-density…

Hosik Jang, Global IP Leader, Joins Marconi to Lead Business in South Korea

DALLAS--(BUSINESS WIRE)--Marconi announced that Hosik Jang has joined as Senior Vice President, South Korea, to…

Asahi Kasei Company ZOLL Medical Corporation Donates $10M to The ZOLL Foundation to Support the Next Generation of Innovative Researchers in Resuscitation and Acute Critical Care

CHELMSFORD, Mass. & TOKYO--(BUSINESS WIRE)--#asahikasei--Asahi Kasei Corporation, a diversified Japanese multinational, today announced that its…

India $60 Billion Car Loan Market, Competition, Forecast & Opportunities, FY2026 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "India Car Loan Market, By Type (New Car & Used Car), By Car…

Chargeurs Launches New Brand Identity for Sustainable Product Collection: Sustainable 360™

Company Expands Sustainable Offering Based on Rapid Growth of Business in First Year Post-Launch NEW…

First Subject Dosed in CANbridge Pharmaceuticals CAN106 Trial for Treatment of Complement Dysregulation Diseases in Singapore

First Compound to Enter Clinical Trial from CANbridge Rare Disease Strategic Partnership with WuXi Biologics…